文献速递生殖医学

扩大雇主生育福利对生殖可及性的影响:2017至2021年单一学术中心分析

Enhancing reproductive access: the influence of expanded employer fertility benefits at a single academic center from 2017 to 2021.
PubMed 文献 · Am J Obstet Gynecol · 2025-05-05

实施后新患者增加162.9%,38-40岁人群比例上升,无不孕女性寻求卵母细胞冷冻和孕前咨询比例增加,自我报告种族多样性无变化。

要点

  • 扩大生育福利后新患者总数从378例增至1208例,增幅162.9%
  • 38-40岁患者比例从12.4%升至17.8%,无不孕女性就诊比例从17.5%升至23.1%
  • 以卵母细胞冷冻为最高治疗级别的患者比例从5.8%升至15.4%

核心结论

  • 单一机构实施生育福利后患者人口学特征和治疗利用发生变化,提示生育福利可能改善医疗可及性并赋权育龄女性进行家庭规划。
  • 自我报告种族多样性未见变化,但卵母细胞冷冻利用显著增加及无不孕问题女性参与家庭规划咨询,突显生育福利在促进主动生殖健康管理中的重要性。

研究设计与样本

  • 回顾性病历审查,于大型城市学术医院系统内生殖门诊开展,时间段为2017至2021年。
  • 共纳入1586例新患者,其中扩大福利实施前(2017-2018年)378例,实施后(2019-2021年)1208例。
  • 采用描述性统计(均值、比例),以卡方检验、Fisher精确检验和Mann-Whitney U检验比较实施前后时期。

主要发现

  • 新患者数从2017至2021年增加162.9%。
  • 38至40岁患者比例从12.4%升至17.8%,41-42岁比例从9.3%降至5.1%,>42岁比例从7.4%降至6.7%,<38岁比例无差异(P=.01)。
  • 自我报告种族和族裔在实施前后无差异,非西班牙裔白人分别为41.5% vs 40.0%,非西班牙裔黑人分别为38.6% vs 39.7%(P=.89)。
  • 无不孕女性就诊比例从17.5%升至23.1%(P=.03),其中卵母细胞冷冻从12.2%升至16.7%,孕前咨询从3.4%升至5.6%(P=.02)。
  • 以卵母细胞冷冻为最高治疗级别的患者比例从5.8%升至15.4%,其他治疗比例无差异(P<.001);首次就诊前患者报告的不孕症减少(P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recognized by the World Health Organization as a disease, infertility carries emotional and financial burdens. With treatments like in vitro fertilization costing approximately $12,400 (not including medications), many Americans may allocate a substantial portion of their annual income to a single assisted reproductive technology cycle. To mitigate this burden, a minority of states mandate varying levels of insurance coverage for fertility treatment. Independent of state legislation, individual employers can also provide fertility benefits. In 2019, 1 academic institution, in a nonmandated state, amended its insurance policy to begin providing up to $25,000 of fertility treatment. Coverage expansion may ease financial stress and promote diversity in treatment access, as data indicate racial disparities in infertility treatment uptake. OBJECTIVE: Our study analyzed demographic shifts and treatment utilization in patients seeking fertility treatment before and after implementation of an expanded fertility treatment insurance benefit at a single institution. STUDY DESIGN: We conducted a retrospective chart review at a reproductive clinic in a large, urban academic hospital system from 2017 to 2021. Analyses included descriptive statistics (means, proportions) and preimplementation (2017-2018) and postimplementation (2019-2021) periods were compared with chi-square tests, Fisher exact tests, and Mann-Whitney U tests. RESULTS: From 2017 to 2021, 1586 new patients accessed fertility services, including 378 prior to expanded fertility benefit coverage (2017-2018) and 1208 after its implementation (2019-2021), representing a 162.9% increase from 2017 to 2021. There was an increase in the proportion of patients ages 38 to 40 years of age seeking care (12.4% vs 17.8%), a decrease in the proportion of older patients (ages 41-42: 9.3% vs 5.1%; age >42: 7.4% vs 6.7%), and no differences in the proportion of patients <38 years (P=.01). There were no differences in self-identified race or ethnicity before and after implementation, with patients most commonly identifying as non-Hispanic White (41.5% vs 40.0%), closely followed by non-Hispanic Black (38.6% vs 39.7%; P=.89). After implementation, a higher proportion of women without infertility sought care (17.5% vs 23.1%; P=.03) specifically in the form of oocyte cryopreservation (12.2% vs 16.7%) and preconception counseling (3.4% vs 5.6%; P=.02). There was an increase in patients pursuing oocyte cryopreservation as highest level of treatment (5.8% vs 15.4%), but no differences in proportions of patients pursuing other treatment (P<.001). Patient-reported infertility prior to first appointment also decreased (P<.001). CONCLUSION: Patient demographics and fertility treatment utilization changed after the adoption of fertility benefits at a single institution, highlighting that implementation of fertility benefits have potential to improve healthcare access and empower reproductively aged women in family planning. No changes were observed in the self-reported racial diversity of patients. However, the marked increase in oocyte cryopreservation utilization and the engagement of women without fertility issues in family planning options underscores the importance of fertility benefits in fostering proactive reproductive health management.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Herweck AM, Delawalla ML, Reed C, et al. Enhancing reproductive access: the influence of expanded employer fertility benefits at a single academic center from 2017 to 2021. Am J Obstet Gynecol. 2025. PMID: 40334766. doi:10.1016/j.ajog.2025.04.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。